Turmeric and Curcumin for Neurodegenerative Diseases examines protective mechanisms of turmeric products and novel nanotechnological therapeutics and biomaterial design strategies to circumvent Alzheimer's Disease, Parkinson's, and liver diseases. With neurodegenerative and liver diseases posing a serious threat to health care systems worldwide, this book addresses how existing nanotechnology and therapeutic strategies have not been as successful in their treatment. In addition to discussing drawbacks, possible future perspectives to overcome these challenges are also examined. Chapters also focus on therapeutic efficacy and drug delivery systems, providing readers with a full summary of research in this field in one handy reference.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Alzheimer's Disease 1. Health Benifits of Turmeric: Emphasis on Anticancer Activity 2. Turmeric Products in Alzheimer's Disease Treatment 3. Curcumin in Alzheimer's Disease Diagnosis and Treatment 4. Curcumin Loaded Drug Delivery Systems in the Treatment of Alzheimer's Disease
Parkinson's Disease 5. Turmeric Products in Parkinson's Disease Treatment 6. Curcumin in Parkinson's Disease Treatment 7. Curcumin Loaded Drug Delivery Systems in the Treatment of Parkinson's Disease
Liver Diseases 8. Turmeric Products in Liver Disease Treatment 9. Curcumin in Liver Disease Treatment 10. Curcumin Loaded Drug Delivery Systems in the Treatment of Liver Diseases
Magisetty Obulesu is a research associate at the Regional Agricultural Research Station, Acharya N.G. Ranga Agricultural University, Tirupati, India. He has 20 years of research and teaching experience. He is also an editorial board of nanotechnology journals including SciFed Nanotech Research Letters, SciFed Drug Delivery Research, Current Updates in Nanotechnology and Journal of Nanotechnology and Materials Science. His research areas include food science, pathology of neurodegenerative diseases such as Alzheimer's disease, designing polymer-based biomaterials such as hydrogels, and development of metal chelators to overcome metal induced toxicity. He has researched Alzheimer's disease and developed an aluminium-induced neurotoxicity rabbit model. Mr. Obulesu's present research focuses on development of redox-active injectable hydrogels of polyion complex. He has written three books and edited two more; he is also the first and corresponding author for majority of his articles.